Fresenius SE & Co KGaA (CHIX:FREd)
€ 37.09 (0%) Market Cap: 22.47 Bil Enterprise Value: 31.11 Bil PE Ratio: 15.35 PB Ratio: 1.14 GF Score: 72/100

Fresenius SE & Co KGaA at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 05:00PM GMT
Release Date Price: €47.7
David Adlington
JPMorgan Chase & Co - Analyst

Good morning, everybody. I'm David Adlington. I head up the research group for JPMorgan in London for Medical Devices and Services. It's my pleasure this morning to introduce Michael Sen from Fresenius SE, and then we'll follow up the presentation with some Q&A. Michael, thank you very much.

Michael Sen
Fresenius SE & Co KGaA - Chairman of the Management Board

So good morning, everybody, and thank you, David. Thanks for having us. I think it's a wonderful opportunity to come together at the JPMorgan Healthcare Conference. We've been talking about that one that it is the industry gathering, a lot of stuff going also around the conferences, meeting periods. But I would also say there could not be any better time for this conference.

And that's why I'm delighted to say, we're committed to life, which is our brand claim. And even the title introducing a health care company even so it might sound very easy is exactly what we're talking about. It's about health care. We got everything in our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot